European association involved in the research and care of children with neuroblastoma - SIOPEN

Improve the outcomes

for patients with neuroblastoma

Events calendar

07
nov.

European Molecular Tumor Board

With the SIOPEN EMTB we aim to combine all expertise to provide a rational recommendation for the therapy of a given neuroblastoma patient, taking both, the specific clinical course as well as the molecular data, into account

Learn more

10
oct.

European Molecular Tumor Board

With the SIOPEN EMTB we aim to combine all expertise to provide a rational recommendation for the therapy of a given neuroblastoma patient, taking both, the specific clinical course as well as the molecular data, into account

Learn more

02
oct.

SIOPEN AGM 2019 - Krakow

2-4 October 2019 VIENNA HOUSE ANDEL’S CRACOW Hotel (Pawia Str. 3, 31-154 Krakow)

Learn more

05
sept.

European Molecular Tumor Board

With the SIOPEN EMTB we aim to combine all expertise to provide a rational recommendation for the therapy of a given neuroblastoma patient, taking both, the specific clinical course as well as the molecular data, into account

Learn more

01
août

European Molecular Tumor Board

With the SIOPEN EMTB we aim to combine all expertise to provide a rational recommendation for the therapy of a given neuroblastoma patient, taking both, the specific clinical course as well as the molecular data, into account

Learn more

04
juil.

European Molecular Tumor Board

With the SIOPEN EMTB we aim to combine all expertise to provide a rational recommendation for the therapy of a given neuroblastoma patient, taking both, the specific clinical course as well as the molecular data, into account

Learn more

06
juin

European Molecular Tumor Board

With the SIOPEN EMTB we aim to combine all expertise to provide a rational recommendation for the therapy of a given neuroblastoma patient, taking both, the specific clinical course as well as the molecular data, into account

Learn more

20
mai

SIOP Europe 2019 Annual Meeting

SIOP Europe 2019 Annual Meeting

Learn more

02
mai

European Molecular Tumor Board

With the SIOPEN EMTB we aim to combine all expertise to provide a rational recommendation for the therapy of a given neuroblastoma patient, taking both, the specific clinical course as well as the molecular data, into account

Learn more

04
avril

European Molecular Tumor Board

With the SIOPEN EMTB we aim to combine all expertise to provide a rational recommendation for the therapy of a given neuroblastoma patient, taking both, the specific clinical course as well as the molecular data, into account

Learn more

07
mars

European Molecular Tumor Board

With the SIOPEN EMTB we aim to combine all expertise to provide a rational recommendation for the therapy of a given neuroblastoma patient, taking both, the specific clinical course as well as the molecular data, into account

Learn more

07
févr.

European Molecular Tumor Board

With the SIOPEN EMTB we aim to combine all expertise to provide a rational recommendation for the therapy of a given neuroblastoma patient, taking both, the specific clinical course as well as the molecular data, into account

Learn more

10
janv.

European Molecular Tumor Board

With the SIOPEN EMTB we aim to combine all expertise to provide a rational recommendation for the therapy of a given neuroblastoma patient, taking both, the specific clinical course as well as the molecular data, into account

Learn more

06
déc.

European Molecular Tumor Board

With the SIOPEN EMTB we aim to combine all expertise to provide a rational recommendation for the therapy of a given neuroblastoma patient, taking both, the specific clinical course as well as the molecular data, into account

Learn more

10
oct.

AGM 2018 - Jerusalem

20
janv.

2009 Foundation SIOPEN Association

SIOPEN Association was established and can start its activities on 20.01.2009

15
oct.

AGM 2008 - Lausanne

10
déc.

AGM 2007 - Tel Aviv

News

Keep you updated on the SIOPEN News !

New Website

21 janv. 2019

New Website

SIOPEN is pleased to present its new website.

Commitee

18 janv. 2019

Commitee

SIOPEN is an international organisation bringing together healthcare professionals

Learn more

SIOPEN AGM

9 oct. 2018

SIOPEN AGM

The SIOPEN AGM took place in Jerusalem from October the 9th to the 11th 2018

Learn more

Newsletter #13

1 avr. 2011

Newsletter #13

Télécharger le fichier

Newsletter #12

1 juin 2010

Newsletter #12

Télécharger le fichier

Newsletter #11

1 oct. 2009

Newsletter #11

Télécharger le fichier

Newsletter #10

1 mars 2009

Newsletter #10

Télécharger le fichier

Newsletter #9

1 mai 2008

Newsletter #9

Télécharger le fichier

1 févr. 2005

Newsletter #6

Télécharger le fichier

1 mai 2004

Newsletter #5

Télécharger le fichier

1 avr. 2003

Newsletter #1

Télécharger le fichier

1 avr. 2003

Newsletter #4

Télécharger le fichier

1 oct. 2002

Newsletter #3

Télécharger le fichier

1 juin 2002

Newsletter #2

Télécharger le fichier

About
SIOPEN,
charity association

Discover the Charities and Foundations
involved in Europe
in the Neuroblastoma Fight

SIOPEN Association

SIOPEN brings together clinicians from across Europe and beyond to improve the outcomes for patients with neuroblastoma.

 

International collaboration is vital because neuroblastoma is uncommon. Collaboration ensures there are enough patients to do clinical studies. This allows us to learn more about the condition and improve treatments. SIOPEN runs a number of large clinical trials examining how best to treat neuroblastoma. In addition, it leads research into the biology of neuroblastoma to provide a better understanding of how the disease develops and how these different types respond to treatment. There are Speciality Committees which focus on specific areas such as biology, pathology, imaging techniques, molecular monitoring of response and surgery.

 

Contact us